Prospective, Observational Study Brodalumab Compared With Other Therapies in the Treatment of Adults With Moderate-to-Severe Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy in the Course of Actual Clinical Care
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Brodalumab (Primary) ; Interleukin-17 inhibitors
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors Ortho Dermatologics; Valeant Pharmaceuticals International
- 06 Apr 2018 Planned initiation date changed from 15 Mar 2018 to 15 Sep 2018.
- 21 Aug 2017 New trial record
- 27 Jul 2017 According to Valeant Pharmaceuticals International media release, Valeant Pharmaceuticals International renamed its dermatolgy unit as Ortho Dermatologics.